Tristel plc (LON:TSTL - Get Free Report) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 430.90 ($5.27) and traded as low as GBX 390 ($4.77). Tristel shares last traded at GBX 390 ($4.77), with a volume of 33,704 shares.
Tristel Price Performance
The firm has a market cap of £185.84 million, a PE ratio of 3,000.00 and a beta of 0.23. The firm's fifty day simple moving average is GBX 417.17 and its two-hundred day simple moving average is GBX 430.50. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12.
Tristel Increases Dividend
The company also recently announced a dividend, which was paid on Friday, December 20th. Investors of record on Thursday, November 28th were issued a GBX 8.28 ($0.10) dividend. The ex-dividend date was Thursday, November 28th. This represents a yield of 2.1%. This is an increase from Tristel's previous dividend of $5.24. Tristel's dividend payout ratio is currently 10,000.00%.
Tristel Company Profile
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Read More
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
